Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis

Author： Lasco A. Catalano A. Morabito N. Gaudio A. Basile G. Trifiletti A. Atteritano M.

ISSN： 0937-941X

Source： Osteoporosis International, Vol.22, Iss.1, 2011-01, pp. : 299-303

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Parathyroid hormone (1–84) and teriparatide in the treatment of postmenopausal osteoporosis

By Bogado1 César E Massari2 Fabio E Zanchetta3 José R

Women's Health, Vol. 2, Iss. 3, 2006-05 ,pp. : 447-457

Future Medicine

Access to resources Recommend Favorite

The effects of teriparatide on the incidence of back pain in postmenopausal women with osteoporosis

By Genant Harry K. Halse Johan Briney Walter G. Xie Li Glass Emmett V. Krege John H.

Current Medical Research and Opinion, Vol. 21, Iss. 7, 2005-07 ,pp. : 1027-1034

Informa Healthcare

Access to resources Recommend Favorite

Effect of teriparatide treatment on endothelial function, glucose metabolism and inflammation markers in patients with postmenopausal osteoporosis

CLINICAL ENDOCRINOLOGY, Vol. 85, Iss. 4, 2016-10 ,pp. : 556-560

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adherence and persistence in patients with severe osteoporosis treated with teriparatide

By Ziller V. Zimmermann S.P. Kalder M. Ziller M. Seker-Pektas B. Hellmeyer L. Hadji P.

Current Medical Research and Opinion, Vol. 26, Iss. 3, 2010-03 ,pp. : 675-681

Informa Healthcare

Access to resources Recommend Favorite

Mixed-treatment comparison of anabolic (teriparatide and PTH 1-84) therapies in women with severe osteoporosis

By Migliore A. Broccoli S. Massafra U. Bizzi E. Frediani B.

Current Medical Research and Opinion, Vol. 28, Iss. 3, 2012-03 ,pp. : 467-473

Informa Healthcare

Access to resources Recommend Favorite